Yong Ben

Yong Ben discloses dealings in 2 companies, chiefly Corbus Pharmaceuticals Holdings, Inc. and BridgeBio Oncology Therapeutics, Inc. In total, 7 filings cover trades dated from 30 May 2024 to 1 October 2026.

No open-market purchase appears, only 1 sale worth €14k. Outside the open market, there are 6 share grants. So far in 2026, the count stands at no purchases and 1 sale.

The record was last updated on 5 October 2026 with a share grant (€3,639) in BridgeBio Oncology Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.